Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Shire Share News (SHP)
SHP Share
Price
SHP Share
News
SHP Share
Chat
SHP Share
Trades
SHP
Live RNS
SHP Share
Charts
SHP Broker
Ratings
SHP Directors
Deals
SHP Financial
Diary
SHP
Fundamentals
SHP Short
Positions
SHP
Media
SHP Company
Research
SHP Company
Timeline
- There is currently no data for SHP
Monday broker round-up
Latest SHP News
- UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push
6 Sep 2019 - UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
14 Aug 2019 - Takeda kicks off sale of Western European drugs - sources
17 Jul 2019 - Japan's Takeda expects binding offers for Latam business by end of May -sources
16 May 2019 - Nikkei snaps 7-day losing streak helped by China's stimulus hopes
15 May 2019 - Nikkei hobbled by trade worries, disappointing earnings
15 May 2019 - UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal
14 May 2019 - Japan's Takeda expects annual loss on Shire deal
14 May 2019
Related News
Goldman upgrades Rentokil to 'buy', hikes price target
(Sharecast News) - Goldman Sachs upgraded Rentokil Initial on Tuesday to 'buy' from 'neutral' and lifted the price target to 590p from 515p.
M&S takes action to cope with extreme temperatures after June heatwave
(Alliance News) - Marks & Spencer Group PLC has said it is taking action across its food stores to cope with extreme heat of up to 45C, after "struggl...
WINNERS & LOSERS: Beauty Tech ups guidance; Ixico to beat expectations
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Shire News
UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push
* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms ...
UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus ma...
Takeda kicks off sale of Western European drugs - sources
By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders fo...
Japan's Takeda expects binding offers for Latam business by end of May -sources
By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by...
Nikkei snaps 7-day losing streak helped by China's stimulus hopes
* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform B...
Nikkei hobbled by trade worries, disappointing earnings
* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earn...
UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal
* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers ...
Japan's Takeda expects annual loss on Shire deal
TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books cost...
Follow the stocks
